“…The beneficial effect of omega-3 PUFA on cardiovascular disease was previously attributed to reducing plasma cholesterol and triacylglycerol levels (Shearer, Savinova, & Harris, 2012) or by inhibiting some of the stages of atherogenesis (Mori, Beilin, Burke, Morris, & Ritchie, 1997;Sneddon, McLeod, Wahle, & Arthur, 2006;Weber, Aepfelbacher, Lux, Zimmer, & Weber, 1991). To explain the lack of association between omega-3 PUFA intake and cardiovascular disease observed by (Rizos et al, 2012) it was postulated that the development of atherosclerotic lesions was not influenced by the levels of cholesterol and triacylglycerol but by the actions of polar lipids that acted as platelet activating factor inhibitors (Karantonis, Antonopoulou, & Perrea, 2006;Nasopoulou, Karantonis, Perrea, Theocharis, & Iliopoulos, 2010;Tsantila et al, 2007;Tsantila et al, 2010). These polar lipids may therefore be responsible to inhibit the onset of atherosclerosis and the development of cardiovascular disease (Nasopoulou et al, 2014).…”